VWU-18899-00024
4 vaccinations
4 coded responses
32 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 902 / CA
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Dose 1 — Pfizer-BioNTech
-
2020-12-21
Registered in v-safe
-
2020-12-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2020-12-22
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2021-01-02
-
2021-01-09
Survey response — day 21, dose 1MedDRA: Headache — Feeling: Fair · Be unable to workFree text: HeadacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-09
-
2021-01-11
Dose 2 — Pfizer-BioNTech
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-17
- 2021-01-20
- 2021-01-25
- 2021-02-01
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-04-12
-
2021-07-12
Survey response — 6 months, dose 2MedDRA: Bronchitis, Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I have a cold that has turned into bronchitis lasting more than 2 weeksMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-12
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-14
Call successfulParticipant prefers to complete VAERS report online
-
2021-10-06
Dose 3 — Pfizer-BioNTech
-
2022-01-13
Survey response — 12 months, dose 2MedDRA: Chills, Fatigue, Headache, Nausea, Oropharyngeal pain, Pain, Pyrexia, Respiratory tract congestion, Rhinorrhoea, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Sore throat, congestion, runny nose, nausea, vomiting, fever, headache, chills, aches, fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-01-13
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-14
-
2022-11-02
Dose 4 — Moderna
- 2022-11-05
- 2022-11-06
-
2022-11-07
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Joint pains, Fatigue or tiredness, NauseaAdult check-in
-
2022-11-08
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
- 2022-11-09
- 2022-11-16
- 2022-11-23
- 2022-11-30
- 2022-12-07
- 2022-12-14
-
2023-02-01
Survey response — 3 months, dose 4MedDRA: Cough, Headache, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-05-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech | |
| 3 | 2021-10-06 | Pfizer-BioNTech | No |
| 4 | 2022-11-02 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-09 | priority 2/3 | |
| 2021-07-12 | Successful 2021-07-14 |
Participant prefers to complete VAERS report online |
| 2022-01-13 | Unsuccessful |
Free text
Release 1 — day 21, dose 1
Symptoms: Headache
Release 9 — 6 months, dose 2
Symptoms: I have a cold that has turned into bronchitis lasting more than 2 weeks
Release 10 — 12 months, dose 2
Symptoms: Sore throat, congestion, runny nose, nausea, vomiting, fever, headache, chills, aches, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchitis | ✓ | ✓ | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release